Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors
Alayna E. Ernster(Wake Forest University), Ashley Ghiaseddin(University of Florida), Kelsey C. Bacharz(University of Florida), Annie Allen(University of Florida), Kaitlyn Melnick(UF Health Shands Hospital), Deborah Sampson(University of Florida), Anjelica Body(University of Florida), Phuong Deleyrolle(University of Florida), Deidre Pereira(University of Florida), Duane A. Mitchell(University of Florida), Maryam Rahman(University of Florida), David D. Tran(University of Florida), Sandra C. Yan(University of Florida), Jennifer St. Clair(University of Florida)
Cited by 9
Related Papers
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
|Proceedings of the National Academy of Sciences|2019|330
Tumor Treating Fields in the Management of Patients with Malignant Gliomas
|Current Treatment Options in Oncology|2020|101
Enhanced recovery after surgery (ERAS) for open transforaminal lumbar interbody fusion: a retrospective propensity-matched cohort study
|The Spine Journal|2021|51
Contemporary RNA Therapeutics for Glioblastoma
|NeuroMolecular Medicine|2021|45